Loading clinical trials...
Loading clinical trials...
A Placebo-Controlled, Randomized, Double-Blind, Parallel-Group, Dose-Finding Trial to Evaluate the Efficacy and Safety of TBS-2 Intranasal Testosterone Gel in Women With Acquired Female Orgasmic Disorder
Conditions
Interventions
Placebo
Low dose TBS-2
+2 more
Locations
53
United States
Radiant Research
Birmingham, Alabama, United States
Medical Affiliated Research Center Inc.
Huntsville, Alabama, United States
Radiant Research Inc.
Chandler, Arizona, United States
Quality of Life Medical Research Center
Tucson, Arizona, United States
Medical Center for Clinical Research
San Diego, California, United States
San Diego Sexual Medicine
San Diego, California, United States
Start Date
May 1, 2012
Primary Completion Date
May 1, 2014
Completion Date
May 1, 2014
Last Updated
August 13, 2018
Lead Sponsor
Acerus Pharmaceuticals Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions